文献
J-GLOBAL ID:202002214580368021
整理番号:20A2336033
Bloom症候群蛋白質(BLM)ヘリカーゼを阻害する新規キナゾリノン誘導体の設計,合成および評価,テロメア領域でDNA損傷を誘発し,PARP阻害剤と相乗作用する【JST・京大機械翻訳】
Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors
著者 (15件):
Wang Chen-Xi
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Zhang Zi-Lin
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Yin Qi-Kun
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Tu Jia-Li
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Wang Jia-En
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Xu Yao-Hao
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Rao Yong
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Ou Tian-Miao
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Huang Shi-Liang
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Li Ding
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Wang Hong-Gen
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Li Qing-Jiang
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Tan Jia-Heng
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Chen Shuo-Bin
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
,
Huang Zhi-Shu
(School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, China)
資料名:
Journal of Medicinal Chemistry
(Journal of Medicinal Chemistry)
巻:
63
号:
17
ページ:
9752-9772
発行年:
2020年
JST資料番号:
D0102A
ISSN:
0022-2623
CODEN:
JMCMAR
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)